UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005068
Receipt number R000006025
Scientific Title The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients
Date of disclosure of the study information 2011/02/10
Last modified on 2014/04/04 11:14:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

Acronym

The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

Scientific Title

The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

Scientific Title:Acronym

The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

Region

Japan


Condition

Condition

Chronic kidney disease and renal anemia

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of Darbepoetin for renal anemia in CKD patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The mean hemoglobin(Hb) change and the achievement rate of Hb target concentration

Key secondary outcomes

Iron kinetics


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Epoetin

Interventions/Control_2

Darbepoetin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

The concentration of Hb is under 11.0mg/dl in CKD patients

Key exclusion criteria

severe heart failure
impossible control of hypertension and so on

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takayasu Ito

Organization

Yamamoto General Hospital

Division name

Internal Medicine

Zip code


Address

3-11 Kotobuki-cho Kuwana city Mie prefecture

TEL

059221211

Email

takayassu@msn.com


Public contact

Name of contact person

1st name
Middle name
Last name Takayasu Ito

Organization

Yamamoto general hospital

Division name

Internal Medicine

Zip code


Address

3-11 Kotobuki-cho Kuwana city Mie prefecture

TEL

0594221211

Homepage URL


Email

takayassu@msn.com


Sponsor or person

Institute

Yamamoto General Hospital

Institute

Department

Personal name



Funding Source

Organization

Yamamoto General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 02 Month 10 Day

Date of IRB


Anticipated trial start date

2010 Year 02 Month 01 Day

Last follow-up date

2012 Year 03 Month 31 Day

Date of closure to data entry

2012 Year 03 Month 31 Day

Date trial data considered complete

2012 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 02 Month 10 Day

Last modified on

2014 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006025


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name